The content is available as a PDF (485.2 KB).
The misleading “pooled effect estimate” of crude data from observational studies at critical risk of bias: The case of Tocilizumab in COVID-19
Prof Imad M Tleyjeh, MD, MSc
Corresponding Author: Imad M. Tleyjeh, MD, MSc, FACP, FIDSA, Professor of Medicine and Epidemiology, Section of Infectious Diseases, King Fahd Medical City, PO Box 59046, Riyadh 11525, Saudi Arabia, Tleyjeh.imad@mayo.edu
Received 2020 Oct 3.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)